Sigma Advanced System Ltd (SIGMAADV) Q1 FY27 Results Analysis: PAT Plunges 81% QoQ, Order Wins at $127 Mn

Cofacto Research Updated August 14, 2026 2 min read
Neutral

Sigma Advanced System Ltd's Q1 FY27 numbers came in mixed. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 13, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 374.28 Cr
PAT (Q1)Rs. 23.90 Cr
EBITDA margin16.28%
EPS (Q1)Rs. 0.54
Market capRs. 13,050.97 Cr
CMPRs. 687.15

Quarter Snapshot

Consolidated revenue grew 16% QoQ to Rs.374 Cr, driven by first full quarter of Nasmyth and AS Strategic consolidation and partial M107 order execution. Operating EBITDA margin remained stable at ~16.3%, but reported PAT (owners) declined 81% QoQ due to normalization of other income and NCI dilution. Major order wins ($127 Mn) and acquisitions position the company for strong FY27 revenue growth, with margin sustainability being the key monitorable.

Key Investment Insights

Key Positives

  • Consolidated revenue from operations grew 15.94% QoQ to Rs.374.28 Cr, driven by first full quarter of consolidation of Nasmyth and AS Strategic and partial M107 order execution.
  • Material costs as a percentage of revenue improved to 37.63% from 52.06% QoQ, indicating better product mix or inventory timing.
  • Operating EBITDA margin (excluding other income) remained stable at 16.28%, close to 17.12% in Q4FY26.
  • Finance costs fell 28.0% QoQ to Rs.7.57 Cr, suggesting debt reduction from internal accruals.
  • Major order wins: M107 shell bodies ($21.97 Mn) and base bleed shells ($104.9 Mn) provide strong revenue visibility for upcoming quarters.
  • Balance sheet strengthened by Rs.460 Cr preferential equity raise, increasing paid-up capital significantly.

Risk Factors

  • PAT attributable to owners collapsed 81% QoQ to Rs.23.90 Cr, primarily due to normalization of other income and NCI dilution from AS Strategic consolidation.
  • Other income dropped to Rs.4.95 Cr from Rs.90.64 Cr QoQ, as prior quarters included large one-time asset sale gains.
  • NCI of Rs.11.51 Cr (32.5% of total PAT) is a significant minority earnings drain going forward, impacting attributable profit.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now